Noticias y Actividades de Bio-Reference Laboratories

Bio-Reference Laboratories es propiedad de Opko Health.

Opko Health es una de las ...

• Russell 3000;
• TOB Iconic 10,000.

Opko Health es una empresa que cotiza bajo el símbolo de cotización OPK (US).

Opko Health posee 3 subsidiarias incluyendo Bio-Reference Laboratories, ModeX Therapeutics y Opko Renal.

Ellos se encuentran en:

• Salud50%
• Farmacia25%
• Otro25%

Ver el organigrama con sus 8 ejecutivos principales

Biografías más buscadas en Bio-Reference Laboratories

• Craig Allen, President and Chief Executive Officer
• Michael Schmid, Senior Vice President and Chief Financial Officer
• Merve Ozkus, Senior Vice President and Chief Information Officer

Crear su alerta
para seguir los movimientos de los ejecutivos en Bio-Reference Laboratories.

Opko Health tiene 2.063 competidores entre los que se incluyen UnitedHealth Group (Estados Unidos), Optum (Estados Unidos) y Siemens Healthineers (Alemania).

Popular M&A news in Salud

• CareSource ha Commonwealth Care Alliance adquirido (publicado el 1 de mayo de 2025).
• Nourish acaba de anunciar una recaudación de fondos de 70 millones de dólares. (publicado el 25 de abril de 2025).
• Accolade and Accolade have announced they will merge  (publicado el 9 de abril de 2025)..

Otros contactos sugeridos en el sector Salud

• Paulo Junqueira Moll - Chief Executive Officer en Rede D'Or Sao Luiz
• Ari Bousbib - Chairman and Chief Executive Officer en IQVIA
• Bryan Roberts - Director en Included Health

Saber más sobre el sector Salud

Últimos comunicados de prensa de Bio-Reference Laboratories

• OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
• Press Releases
• OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
• Labcorp Announces Acquisition of Select Assets of BioReference Health’s Innovative Oncology and Related Clinical Testing Services Businesses
• OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
• OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
• OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
• OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results
• ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
• View more press releases Close

Redes sociales sobre Bio-Reference Laboratories

• Bio-Reference Laboratories en Wikipedia, Google News y Yahoo Finance
• Bio-Reference Laboratories en LinkedIn, Twitter y YouTube